Suppr超能文献

[晚期鼻腔鼻窦恶性肿瘤的内镜手术]

[Endoscopic surgery for advanced malignant nasal and sinus tumors].

作者信息

Ran Qian, Chen Lei, Wang Rong-guang, Wang Hong-tian

机构信息

Department of Otorhinolaryngology Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing 100853, China.

出版信息

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Jun;46(6):469-74.

Abstract

OBJECTIVE

To evaluate the effect of endoscopic surgery for advanced malignant tumors in the nasal cavity and paranasal sinuses.

METHODS

A retrospective data analysis was performed on 49 patients with advanced sinonasal tumors undergoing either an exclusive endoscopic approach or with a complemental approach from January 2004 to October 2010. Forty-nine patients were considered eligible for the present analysis, among them, T3:T4a:T4b were 12:13:24 (T stage was assessed with the sixth editions of the UICC staging systems). The histotypes encountered were squamous cell carcinoma 20 cases, adenocarcinoma 12 cases, mucosal melanoma 8 cases, olfactory neuroblastoma 6 cases, others 3 cases. These patients were operated on either by an exclusive endoscopic endonasal approach or with a complementary external approach; 36 patients received adjuvant radiotherapy or/and chemotherapy. The data were analyzed by Kaplan-Meier method and Log-rank test.

RESULTS

The hemorrhage varied from 200 to 5000 ml during the operation, with an average of 600 ml. The post-operative complications were rare, 1 patient lost her sight after operation, and no patient got infected at the site of operation (nor intracranial infection). After full amount of radiotherapy, no cerebrospinal fluid rhinorrhea was found. Four patients (8.2%) lost to follow-up. Sixteen patients died during the follow-up period, only three of them were without craniocerebral or orbital invasion. Four in 9 patients in the other pathological group (with the pathology of olfactory neuroblastoma or glioma etc), which had a poor prognosis, died during the follow-up period, of them, 3 had definitive evidence of intracranial metastasis, and none of the nine patients had been followed-up beyond 25 months. The 2 and 3 year disease-free rates were 34.2% and 21.4%, and overall survival rates were 62.5% and 58.4% respectively. The T stage, margin status, and whether accepted post operative adjuvant therapy were significant factors in predicting disease recurrence (χ² were 7.7, 4.9, 6.8 respectively and P < 0.05).

CONCLUSIONS

Now the endoscopic techniques with or without complementary approaches is an effective way for complete tumor removal. With postoperative complementary therapy, it provides a satisfactory survival rate with few side effects and better quality of life.

摘要

目的

评估鼻内镜手术治疗鼻腔及鼻窦晚期恶性肿瘤的效果。

方法

对2004年1月至2010年10月期间接受单纯鼻内镜手术或联合其他手术入路的49例鼻窦晚期肿瘤患者进行回顾性数据分析。49例患者符合本分析标准,其中T3:T4a:T4b为12:13:24(T分期采用国际抗癌联盟第六版分期系统评估)。组织学类型包括鳞状细胞癌20例、腺癌12例、黏膜黑色素瘤8例、嗅神经母细胞瘤6例、其他3例。这些患者采用单纯鼻内镜鼻内入路或联合外部入路进行手术;36例患者接受了辅助放疗或/和化疗。数据采用Kaplan-Meier法和Log-rank检验进行分析。

结果

手术中出血量在200至5000毫升之间,平均为600毫升。术后并发症少见,1例患者术后失明,无患者手术部位感染(包括颅内感染)。足量放疗后,未发现脑脊液鼻漏。4例患者(8.2%)失访。随访期间16例患者死亡,其中仅3例无颅脑或眼眶侵犯。9例其他病理类型组(嗅神经母细胞瘤或胶质瘤等病理)患者预后较差,随访期间4例死亡,其中3例有明确的颅内转移证据,9例患者均未随访超过25个月。2年和3年无病生存率分别为34.2%和21.4%,总生存率分别为62.5%和58.4%。T分期、切缘状态以及是否接受术后辅助治疗是预测疾病复发的重要因素(χ²分别为7.7、4.9、6.8,P<0.05)。

结论

目前,无论是否联合其他手术入路,鼻内镜技术都是完整切除肿瘤的有效方法。联合术后辅助治疗时,可提供令人满意的生存率,副作用少,生活质量更好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验